Catalyst Wire Dossier Catalyst Wire Dossier

IxCell hUC-MSC-P

human umbilical cord mesenchymal stem cells · Shanghai IxCell Biotechnology Co., LTD
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IxCell hUC-MSC-P, covering 2025-02-14 to 2025-02-14. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells (IxCell hUC-MSC-P) in the Treatment of CTD-ILD [Phase 1]

See pricing